Cause of death, by non-communicable diseases, ages 60+, female in Euro area
Euro area: Cause of death, by non-communicable diseases, ages 60+, female was 82.8% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 60+, female in Euro area, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 60+.
Analysis
In 2021, cause of death, by non-communicable diseases, ages 60+, female in Euro area stood at 82.8%. That is the lowest value across all 6 years on record.
Compared with earlier readings it is down 0.1% on the previous year and down 10.2% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 60+, female in Euro area peaked at 92.3% in 2000 and was at its lowest, 82.8%, in 2021.
Euro area ranks 5th of 47 groups on this measure, in the top 10%.
Cause of death, by non-communicable diseases, ages 60+, female in Euro area, year by year
| Year | % of total female deaths ages 60+ | Change |
|---|---|---|
| 2000 | 92.3% | — |
| 2010 | 92.2% | -0.1% |
| 2015 | 91.1% | -1.2% |
| 2019 | 90.6% | -0.5% |
| 2020 | 82.9% | -8.5% |
| 2021 | 82.8% | -0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.3% | 92.3% | 92.3% | 1 |
| 2010s | 91.3% | 90.6% | 92.2% | 3 |
| 2020s | 82.8% | 82.8% | 82.9% | 2 |
Countries ranked near Euro area
- 2 China 94.2% compare
- 3 Turkmenistan 93.3% compare
- 4 Iceland 92.3% compare
- 5 Australia 91.9% compare
- 6 New Zealand 91.4% compare
- 7 Samoa 91.3% compare
- 8 Uzbekistan 91.3% compare
More health data for Euro area
- Population ages 30-34, female, per capita 0.0286 units per person (2025)
- Population ages 35-39, male, annual growth rate 0.1709 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0309 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -0.1844 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0298 units per person (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 25-29, female, per capita 0.027 units per person (2025)
- Population ages 25-29, male, annual growth rate 0.1302 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 60+, female in Euro area?
- Cause of death, by non-communicable diseases, ages 60+, female in Euro area was 82.8% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 60+, female recorded in Euro area?
- The highest recorded value was 92.3% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 60+, female recorded in Euro area?
- The lowest recorded value was 82.8% in 2021.
- How does Euro area rank for cause of death, by non-communicable diseases, ages 60+, female?
- Euro area ranks 5th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, ages 60+, female rising or falling in Euro area?
- Over the last ten years it is down 10.2%. The long-run trend across the full record is falling.
- Where does this Euro area data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.